OBJECTIVES: To review 13 years' data from a unit for grown ups with congenital heart disease (GUCH) to understand the change in surgical practice. METHODS: Records were reviewed of patients over 16 years of age undergoing surgery between 1 January 1990 and 31 December 2002 in a dedicated GUCH unit. Patients with atrial septal defects were included but not those with Marfan's syndrome or undergoing a first procedure for bicuspid aortic valves. Three equal time periods of 52 months were analysed. RESULTS: Of 474 operations performed, 162 (34.2%) were repeat operations. The percentage of repeat operations increased from 24.8% (41 of 165) in January 1990-April 1994 to 49.7% (74 of 149) in September 1998-December 2002. Mortality was 6.3% (n = 30). The median age decreased from 25.4 years (interquartile range 18.7) in January 1990-April 1994 to 23.9 (interquartile range 17.3) in September 1998-December 2002 (p = 0.04). The proportion of patients with a "simple" diagnosis decreased from 45.4% (74 or 165) in January 1990-April 1994 to 27.5% (41 of 149) in September 1998-December 2002 (p = 0.013). Pulmonary valve replacements in operated tetralogy of Fallot increased from one case in January 1990-April 1994 to 23 cases in September 1998-December 2002 and conduit replacement increased from five cases to 17. However, secundum atrial septal defect closures decreased from 35 cases to 14 (p < 0.0001). The estimated cost (not including salaries and prosthetics) incurred by an adult patient with congenital heart disease was pound2290 compared with pound2641 for a patient undergoing coronary artery bypass grafting. CONCLUSION: Despite the impact of interventional cardiology, the total number of surgical procedures remained unchanged. The complexity of the cases increased particularly with repeat surgery. Nevertheless, the patients do well with low mortality and the inpatient costs remain comparable with costs of surgery for acquired disease.
OBJECTIVES: To review 13 years' data from a unit for grown ups with congenital heart disease (GUCH) to understand the change in surgical practice. METHODS: Records were reviewed of patients over 16 years of age undergoing surgery between 1 January 1990 and 31 December 2002 in a dedicated GUCH unit. Patients with atrial septal defects were included but not those with Marfan's syndrome or undergoing a first procedure for bicuspid aortic valves. Three equal time periods of 52 months were analysed. RESULTS: Of 474 operations performed, 162 (34.2%) were repeat operations. The percentage of repeat operations increased from 24.8% (41 of 165) in January 1990-April 1994 to 49.7% (74 of 149) in September 1998-December 2002. Mortality was 6.3% (n = 30). The median age decreased from 25.4 years (interquartile range 18.7) in January 1990-April 1994 to 23.9 (interquartile range 17.3) in September 1998-December 2002 (p = 0.04). The proportion of patients with a "simple" diagnosis decreased from 45.4% (74 or 165) in January 1990-April 1994 to 27.5% (41 of 149) in September 1998-December 2002 (p = 0.013). Pulmonary valve replacements in operated tetralogy of Fallot increased from one case in January 1990-April 1994 to 23 cases in September 1998-December 2002 and conduit replacement increased from five cases to 17. However, secundum atrial septal defect closures decreased from 35 cases to 14 (p < 0.0001). The estimated cost (not including salaries and prosthetics) incurred by an adult patient with congenital heart disease was pound2290 compared with pound2641 for a patient undergoing coronary artery bypass grafting. CONCLUSION: Despite the impact of interventional cardiology, the total number of surgical procedures remained unchanged. The complexity of the cases increased particularly with repeat surgery. Nevertheless, the patients do well with low mortality and the inpatient costs remain comparable with costs of surgery for acquired disease.
Authors: C A Warnes; R Liberthson; G K Danielson; A Dore; L Harris; J I Hoffman; J Somerville; R G Williams; G D Webb Journal: J Am Coll Cardiol Date: 2001-04 Impact factor: 24.094
Authors: J Therrien; A Dore; W Gersony; L Iserin; R Liberthson; F Meijboom; J M Colman; E Oechslin; D Taylor; J Perloff; J Somerville; G D Webb Journal: Can J Cardiol Date: 2001-09 Impact factor: 5.223
Authors: J Therrien; S C Siu; L Harris; A Dore; K Niwa; J Janousek; W G Williams; G Webb; M A Gatzoulis Journal: Circulation Date: 2001-05-22 Impact factor: 29.690
Authors: Teun van der Bom; A Carla Zomer; Aeilko H Zwinderman; Folkert J Meijboom; Berto J Bouma; Barbara J M Mulder Journal: Nat Rev Cardiol Date: 2010-11-02 Impact factor: 32.419
Authors: Candice K Silversides; Ariane Marelli; Luc Beauchesne; Annie Dore; Marla Kiess; Omid Salehian; Timothy Bradley; Jack Colman; Michael Connelly; Louise Harris; Paul Khairy; Seema Mital; Koichiro Niwa; Erwin Oechslin; Nancy Poirier; Markus Schwerzmann; Dylan Taylor; Isabelle Vonder Muhll; Helmut Baumgartner; Lee Benson; David Celermajer; Matthias Greutmann; Eric Horlick; Mike Landzberg; Folkert Meijboom; Barbara Mulder; Carole Warnes; Gary Webb; Judith Therrien Journal: Can J Cardiol Date: 2010-03 Impact factor: 5.223
Authors: Susanna Price; Sian Isobel Jaggar; Simon Jordan; Sarah Trenfield; Mohammed Khan; Babulal Sethia; Darryl Shore; Timothy W Evans Journal: Intensive Care Med Date: 2007-02-27 Impact factor: 17.440